Generali Asset Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Sell
3,140
-502
-14% -$83.6K 0.01% 414
2026
Q1
$764K Buy
+3,642
New +$915K 0.02% 401
2025
Q3
Sell
-2,809
Closed -$883K 517
2025
Q2
$883K Sell
2,809
-2,299
-45% -$664K 0.02% 419
2025
Q1
$1.34M Sell
5,108
-7,393
-59% -$2M 0.03% 365
2024
Q4
$3.26M Buy
+12,501
New +$3.15M 0.08% 222

Other funds holding PODD

Generali Asset Management's PODD Position: Q2 2026 in Review

Generali Asset Management reduced its Insulet (PODD) stake by 14% in Q2 2026, selling an estimated $83.6K and leaving 3,140 shares worth $478K. The position accounts for 0.01% of the portfolio, ranked #414.

Generali Asset Management first reported a position in PODD in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.26M in Q4 2024. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Generali Asset Management held 3,140 shares of Insulet worth $478K as of Q2 2026.
  • Generali Asset Management sold 502 Insulet shares in Q2 2026, an estimated $83.6K.
  • Insulet made up 0.01% of Generali Asset Management's portfolio in Q2 2026, its #414 holding.
  • Generali Asset Management first reported a position in Insulet in Q4 2024 and has held it in 5 quarters since.
  • Generali Asset Management's Insulet position peaked at $3.26M in Q4 2024.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Generali Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.